Neuronetics (STIM) Announces Proposed Public Offering of Common Stock

Go back to Neuronetics (STIM) Announces Proposed Public Offering of Common Stock

Neuronetics Announces Proposed Public Offering of Common Stock

January 28, 2021 4:01 PM UTC

MALVERN, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the Company), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that it has commenced an underwritten public offering of its common stock. The Company intends to grant the underwriters a 30-day option to purchase an additional 15% of the shares of its common stock offered in the public offering. The offering is subject to market and other conditions, and there can... More